RJA
EXEL icon

Ross\Johnson & Associates’s Exelixis EXEL Stock Holding History

Ross\Johnson & Associates’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-40
Closed -$1.48K – 254
2025
Q1 		$1.48K Buy
+40
New +$1.43K 0.03% 187

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ross\Johnson & Associates's EXEL Position: Q2 2025 in Review

Ross\Johnson & Associates sold out of Exelixis (EXEL) in Q2 2025, closing a stake of 40 shares — an estimated $1.48K sold.

Ross\Johnson & Associates first reported a position in EXEL in Q1 2025 and held it in 1 quarter. The position peaked at $1.48K in Q1 2025. 633 funds tracked by Wall St. Rank hold EXEL as of Q2 2025.

  • Ross\Johnson & Associates reported no remaining Exelixis position as of Q2 2025 after selling out during the quarter.
  • Ross\Johnson & Associates sold 40 Exelixis shares in Q2 2025, an estimated $1.48K.
  • Ross\Johnson & Associates first reported a position in Exelixis in Q1 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's Exelixis position peaked at $1.48K in Q1 2025.
  • 633 funds tracked by Wall St. Rank held Exelixis as of Q2 2025.

Based on Ross\Johnson & Associates's 13F filing for Q2 2025, filed 15 Aug 2025.